An upcoming concentrate formulation used to treat inflammatory conditions includes sorbitol, posing a fatal risk for patients with hereditary fructose ...

A 10-year US study reports an increase in infantile hemangioma visits over a decade, with topical beta-blocker prescribing rising sharply. ...

Now physicians can tell patients that success rates with egg freezing are similar to those for patients using other assisted ...

Personalized risk messages did not raise colorectal cancer screenings, a new study finds. Medscape Medical News Source link : https://www.medscape.com/viewarticle/risk-based-messages-did-not-raise-overall-screening-rates-2025a1000no1?src=rss ...

Antibody levels after mpox vaccination decline more rapidly than those after natural mpox infection, and people living with HIV show ...

Share on PinterestHemorrhoids are common, but spending less time on the toilet with your phone can help lower your risk. ...

In patients with acute exacerbations of chronic obstructive pulmonary disease, anemia is common and linked to increased 1-year readmission and ...

A false colour image of the quantum router circuitMIT SQUILL foundry Quantum computers may be able to run useful algorithms ...

High rates of recurrence of DFUs and reintervention for chronic limb-threatening ischemia impose a notable, unrecognized burden on patients and ...

Compared with placebo, a single application of the LSD-based medication MM120 is linked to rapidly reduced anxiety and depressive symptoms ...

Semaglutide and other GLP-1 receptor agonists show robust benefit in polycythemia vera, but it’s unclear whether this is due to ...

Nearly 80% of cancer drugs approved by the FDA in recent years have clinical trial uncertainties, but journals and guidelines ...

Amy ColeMidlands Today andTanya GuptaBBC News, West MidlandsBBCStaff practise on Linda the mannequin in the simulation laboratoryA simulation laboratory that ...

A retrospective study finds that rates of malnutrition and other adverse clinical outcomes are higher 1 month before surgery than ...

(MedPage Today) -- First-line osimertinib (Tagrisso) plus chemotherapy significantly improved survival versus osimertinib monotherapy in patients with EGFR-mutated advanced non-small ...

The FLAURA2 trial establishes a new standard of care for EGFR-mutated NSCLC, according to the authors of new research. Medscape ...

Median PFS benefit was just over 3 months in patients with EGFR-mutant NSCLC who had tumor suppressor gene co-mutations. Medscape ...

Jenny ReesHealth correspondent, BBC WalesBritish Medical AssociationDr Alice Gatenby has been told "it's too much hassle" to change shifts to ...

(MedPage Today) -- SEATTLE -- GLP-1 receptor agonist use was tied with a reduced risk for fracture among older women ...

(MedPage Today) -- SEATTLE -- Adolescents and young adults who underwent metabolic and bariatric surgery had lower bone mineral density ...